.png)
CTO
HSE AG, Switzerland
Konstantin Lutze brings over 25 years of expertise in developing laboratory automation and in-vitro diagnostics systems. Prior to his role as CTO at HSE-AG, he served as the VP of Instrument Development at QIAGEN. In that capacity, he spearheaded the successful development and launch of a cutting-edge next-generation sequencing platform. As CTO, he now oversees technology management and propels innovations in nucleic acid, protein, and cell analysis. His leadership enables HSE-AG to deliver significant value to its customers through advanced technological solutions.